Fig. 1From: Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective studyThe frequency of infectious events in all patients post 1Â month of MSCI. The numbers in the columns indicate the number of patients experienced infectionsBack to article page